Clovis Oncology, Inc. was a big mover last session, as the company saw its shares rise above 5% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up almost 37% in the past one-month time frame.

In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.       

Clovis Oncology currently carries a Zacks Rank # 3 (Hold) while its Earnings ESP is 0.00%.

Clovis Oncology, Inc. Price

 

Clovis Oncology, Inc. Price | Clovis Oncology, Inc. Quote

Another well-ranked Medical-Biomedical and Genetics stock is Enzo Biochem, Inc. (ENZ Quick QuoteENZ - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CLVS going up? Or down? Predict to see what others think: Up or Down

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>